Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case–control study and a meta-analysis

Immunologic Research

Volumn 64, Issue 4, 2016, Pages 1041-1052

  Huang, Xiao Lei ^a   Wu, Guo Cui ^a   Wang, Yu Jie ^a   Yang, Xiao Ke ^a   Yang, Guo Jun ^a   Tao, Jin Hui ^a   Duan, Yu ^a   Yan, Jun Wei ^a   Li, Xiang Pei ^a   Ye, Dong Qing ^a   Wang, Jing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Chinese population; Interleukin 1; Polymorphism; Systemic sclerosis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 33; IL33 PROTEIN, HUMAN; INTERLEUKIN 18 PROTEIN, HUMAN;

ADULT; ALLELE DISCRIMINATION ASSAY; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PROCEDURES; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; CHINA; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; META ANALYSIS; MIDDLE AGED;

ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-1ALPHA; INTERLEUKIN-33; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC;

EID: 84964319133     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-016-8797-7     Document Type: Article

References (28)

1. Chora I, Guiducci S, Manetti M, Romano E, Mazzotta C, Bellando-Randone S, et al. Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis. Autoimmun Rev. 2015;14(4):314–22.
2. Broen JC, Coenen MJ, Radstake TR. Genetics of systemic sclerosis: an update. Curr Rheumatol Rep. 2012;14(1):11–21.
3. Zhang L, Yan JW, Wang YJ, Wan YN, Wang BX, Tao JH, et al. Association of interleukin 1 family with systemic sclerosis. Inflammation. 2014;37(4):1213–20.
4. Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Hara M, Kotake S, et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 2003;48(1):186–92.
5. Mattuzzi S, Barbi S, Carletto A, Ravagnani V, Moore PS, Bambara LM, Scarpa A. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 2007;34(5):997–1004.
6. Beretta L, Cappiello F, Moore JH, Barili M, Greene CS, Scorza R. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum. 2008;59(7):974–83.
7. Huang J, Li M, Tian Z, Wang Q, Liu Y, Xu D, et al. Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-115–21.
8. Beretta L, Bertolotti F, Cappiello F, Barili M, Masciocchi M, Toussoun K, et al. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Hum Immunol. 2007;68(7):603–9.
9. Hutyrová B, Lukác J, Bosák V, Buc M, du Bois R, Petrek M. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. J Rheumatol. 2004;31(1):81–4.
10. Abtahi S, Farazmand A, Mahmoudi M, Ashraf-Ganjouei A, Javinani A, Nazari B, et al. IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis. Int J Immunogenet. 2015;42(6):423–7.
11. Lea W, Lee YH. The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis. Joint Bone Spine. 2012;79(4):370–4.
12. Isik N, Arman A, Canturk IA, Gurkan AC, Candan F, Aktan S, et al. Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population. Int J Neurosci. 2013;123(10):711–8.
13. Liu N, Li X, Liu C, Zhao Y, Cui B, Ning G. The association of interleukin-1α and interleukin-1 beta polymorphisms with the risk of Graves’ disease in a case-control study and meta-analysis. Hum Immunol. 2010;71(4):397–401.
14. Peng WJ, Wang BX, Pan HF, Wang J. Association of interleukin 1α promoter polymorphism (-889C/T) with susceptibility to systemic sclerosis. J Rheumatol. 2012;39(8):1755.
15. Inoue A, Obayashi K, Sonoda Y, Nakamura A, Ueno T, Kuhara S, et al. Regulation of matrix metalloproteinase-1 and alpha-smooth muscle actin expression by interleukin-1 alpha and tumour necrosis factor alpha in hepatic stellate cells. Cytotechnology. 2016. doi:10.1007/s10616-016-9948-3.
16. McDowell TL, Symons JA, Ploski R, Førre O, Duff GW. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995;38(2):221–8.
17. Um JY, Rim HK, Kim SJ, Kim HL, Hong SH. Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLoS One. 2011;6(12):1–10.
18. Oliveira A, Dinis-Oliveira RJ, Nogueira A, Gonçalves F, Silva P, Vieira C, et al. Interleukin-1β genotype and circulating levels in cancer patients: metastatic status and pain perception. Clin Biochem. 2014;47(13–14):1209–13.
19. Al-Tahhan MA, Etewa RL, El Behery MM. Association between circulating interleukin-1 beta (IL-1beta) levels and IL-1beta C-511T polymorphism with cervical cancer risk in Egyptian women. Mol Cell Biochem. 2011;353(1–2):159–65.
20. Olsson S, Holmegaard L, Jood K, Sjögren M, Engström G, Lövkvist H, et al. Genetic variation within the interleukin-1 gene cluster and ischemic stroke. Stroke. 2012;43(9):2278–82.
21. Heidary M, Rakhshi N, Pahlevan Kakhki M, Behmanesh M, Sanati MH, Sanadgol N, et al. The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients. J Neurol Sci. 2014;343(1–2):41–5.
22. Nadeem A, Mumtaz S, Naveed AK, Aslam M, Siddiqui A, Lodhi GM, et al. Gene-gene, gene-environment, gene-nutrient interactions and single nucleotide polymorphisms of inflammatory cytokines. World J Diabetes. 2015;6(4):642–7.
23. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–90.
24. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol. 2011;30(6):825–30.
25. Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, et al. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis. 2011;70(10):1876–8.
26. Terras S, Opitz E, Moritz RK, Höxtermann S, Gambichler T, Kreuter A. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis. 2013;72(1):144–5.
27. Koca SS, Pehlivan Y, Kara M, Alibaz-Oner F, Oztuzcu S, Yilmaz N, et al. The IL-33 gene is related to increased susceptibility to systemic sclerosis. Rheumatol Int. 2016;36(4):579-84.
28. Sedimbi SK, Hägglöf T, Karlsson MC. IL-18 in inflammatory and autoimmune disease. Cell Mol Life Sci. 2013;70(24):4795–808.